Analytical Data
-
Gene name
HBe1
- Application
-
Alternative Names
Epsilon-globin
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P02100
-
Expression Region
Val2~His147
-
Molecular Weight
46kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HBe1 recombinant protein has gained significant attention in the field of virology and immunology due to its association with hepatitis B virus (HBV) infection. HBV affects hundreds of millions of individuals globally, potentially leading to chronic liver diseases, including cirrhosis and hepatocellular carcinoma. The precore protein, which includes HBe1, plays a crucial role in the virion assembly and immune response evasion mechanisms of HBV. Understanding the structure and function of the HBe1 protein can provide insights into the viral replication cycle and host interactions, which are critical for developing therapeutics and vaccines. Furthermore, studies have shown that HBe1 can modulate the immune response by influencing T-cell activation and antibody production. As a result, generating and characterizing HBe1 recombinant protein is essential for investigating its immunogenic properties and potential as a vaccine candidate. Researchers have been focusing on employing various expression systems to produce HBe1 efficiently, enabling detailed studies on its biological function and the host immune response. Overall, HBe1 research is pivotal to advancing our understanding of HBV biology and improving clinical outcomes for affected patients.
